Fortinet, Inc. vs Vertex Pharmaceuticals Incorporated
μκ°μ λ°λ₯Έ μκ°μ΄μ‘ λΉκ΅
Fortinet, Inc.
$132.1B
μμ #125
Vertex Pharmaceuticals Incorporated
$132.8B
μμ #123
μκ°μ λ°λ₯Έ μκ°μ΄μ‘
μ°λλ³ λΉκ΅
| μ°λ | Fortinet, Inc. | Vertex Pharmaceuticals Incorporated | μ λ |
|---|---|---|---|
| 2026 | $132.1B | $132.8B | Vertex Pharmaceuticals Incorporated |
| 2025 | $58.2B | $115.1B | Vertex Pharmaceuticals Incorporated |
| 2024 | $69.2B | $102.2B | Vertex Pharmaceuticals Incorporated |
| 2023 | $42.9B | $103.3B | Vertex Pharmaceuticals Incorporated |
| 2022 | $35.8B | $73.3B | Vertex Pharmaceuticals Incorporated |
| 2021 | $52.7B | $55.7B | Vertex Pharmaceuticals Incorporated |
| 2020 | $21.8B | $60.0B | Vertex Pharmaceuticals Incorporated |
| 2019 | $15.6B | $55.6B | Vertex Pharmaceuticals Incorporated |
| 2018 | $10.3B | $42.1B | Vertex Pharmaceuticals Incorporated |
| 2017 | $6.4B | $38.0B | Vertex Pharmaceuticals Incorporated |
| 2016 | $4.4B | $18.7B | Vertex Pharmaceuticals Incorporated |
| 2015 | $4.6B | $31.9B | Vertex Pharmaceuticals Incorporated |
| 2014 | $4.5B | $30.2B | Vertex Pharmaceuticals Incorporated |
| 2013 | $2.8B | $18.9B | Vertex Pharmaceuticals Incorporated |
| 2012 | $3.1B | $10.6B | Vertex Pharmaceuticals Incorporated |
| 2011 | $3.2B | $8.4B | Vertex Pharmaceuticals Incorporated |
| 2010 | $2.4B | $8.9B | Vertex Pharmaceuticals Incorporated |
| 2009 | $1.3B | $10.9B | Vertex Pharmaceuticals Incorporated |